Biomarker correlation with response and PFS
| Response . | PD-L1 staining . | . | ||
|---|---|---|---|---|
| Negative . | Weakly + . | Positive . | . | |
| N = 10 (%) . | N = 6 (%) . | N = 13 (%) . | P value . | |
| sCR/CR/VGPR | 0/0/2 (20) | 0 | 1/1/5 (54) | .06 |
| PFS, median, mo (95% CI) | 17.4 | 17.5 | NR | |
| 10.6-18.4 | 6.4-17.5 | 3.7, NR | ||
| Response . | PD-L1 staining . | . | ||
|---|---|---|---|---|
| Negative . | Weakly + . | Positive . | . | |
| N = 10 (%) . | N = 6 (%) . | N = 13 (%) . | P value . | |
| sCR/CR/VGPR | 0/0/2 (20) | 0 | 1/1/5 (54) | .06 |
| PFS, median, mo (95% CI) | 17.4 | 17.5 | NR | |
| 10.6-18.4 | 6.4-17.5 | 3.7, NR | ||
| . | PD-1/CD staining . | . | ||
|---|---|---|---|---|
| CD3+/PD1+ . | CD3+/PD1− . | CD3−/PD1− . | . | |
| N = 6 (%) . | N = 10 (%) . | N = 22 (%) . | . | |
| sCR/CR/VGPR | 0 | 0/1/4 (50) | 3/0/2 (23) | |
| PFS, median, mo (95% CI) | 6.3 | 16.5 | 17.5 | |
| 2.6, NR | 10.6, NR | 11.7, NR | .05 | |
| . | PD-1/CD staining . | . | ||
|---|---|---|---|---|
| CD3+/PD1+ . | CD3+/PD1− . | CD3−/PD1− . | . | |
| N = 6 (%) . | N = 10 (%) . | N = 22 (%) . | . | |
| sCR/CR/VGPR | 0 | 0/1/4 (50) | 3/0/2 (23) | |
| PFS, median, mo (95% CI) | 6.3 | 16.5 | 17.5 | |
| 2.6, NR | 10.6, NR | 11.7, NR | .05 | |